Director/PDMR Shareholding

RNS Number : 8542O
JPMorgan Claverhouse IT PLC
14 June 2022
 

JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC

Information disclosed in accordance with DTR 3.1.2-A, incorporating Article 19(1) of the Market Abuse Regulation

1.

 

Details of the person discharging managerial responsibilities / persons closely associated

a)

Name

David Fletcher

2.

Reason for the notification 

a)

Position / Status

Director

b)

Initial notification/ Amendment

Initial Notification

3.

Details of the issuer

 

a)

Name

JPMorgan Claverhouse Investment Trust plc

b)

Legal Identifier Code

549300NFZYYFSCD52W53

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 25p each

ISIN: GB0003422184

b)

Nature of the Transaction

Acquisition of shares through dividend reinvestment by PDMR and PCA.

c)

Price and Volume

Price

Volume

680.00pence

680.00pence

 

48

7

 

d)

Aggregated information

Aggregated price

Price

N/A single transaction

e)

Date of transaction

13th June 2022

f)

Holding post the transaction

5,205 Ordinary shares

g)

Place of transaction

London Stock Exchange, XLON

 

14 June 2022

JPMorgan Claverhouse Investment Trust plc (the" Company")

Director / PDMR Shareholding

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFISRSISLIF
UK 100